How effective is medical cannabis therapy with cannabidiol (CBD), the non-psychoactive component of the hemp plant, in adults with neuropsychiatric symptoms as a consequence of Alzheimer's dementia? A study from Colombia concluded that CBD-rich oil reduces the severity of symptoms in affected individuals as well as the emotional and physical care burden on relatives...
Taking various medications can serve as a possible early indicator of dementia at a younger age. Danish researchers came to this conclusion. They examined the medication intake of people who developed dementia before the age of 65. An often overlooked patient group is people with a rare form of dementia, the so-called „Young...
When people with dementia take antipsychotics, it is associated with an increased risk of adverse events such as stroke, heart failure, and pneumonia. This was the conclusion of researchers from Great Britain, Norway, and Greece. Researchers from Great Britain pointed to the current care situation in their study, published in 2024: „Despite safety concerns..."
Mit dem „digiDEM Bayern Präventionscoach®“ stellt das Digitale Demenzregister Bayern (digiDEM Bayern) ein Online-Angebot zur Reduzierung des persönlichen Demenzrisikos vor. Der „digiDEM Bayern Präventionscoach®“ ist ein innovativer digitaler Wegweiser für einen gesunden Lebensstil und kann dazu beitragen, das Risiko einer Demenzerkrankung zu senken. Neben zahlreichen wissenschaftlich abgesicherten Informationen rund um …
The Bavarian Digital Dementia Register (digiDEM Bayern) has reached a new high with 2,500 participants from all over Bavaria. This makes the dementia research project the largest dementia registry in Germany and one of the most extensive long-term data collection projects in dementia research in the European Union (EU). In the project, funded by the Bavarian State Ministry...
Digital technologies have long been widespread and reach a wide variety of user groups. To what extent digital technologies can help prevent social isolation and loneliness in people with dementia is hardly or little researched. We present two studies that shed light on this. The appeal from scientists from Great Britain and…
How can the loneliness of seniors be combated – with scientific evidence? A review by researchers from the USA provides valuable insights for policymakers, among others, so that corresponding programs and support services can be provided flexibly. During the COVID-19 pandemic, the topic of „loneliness among seniors“ received a lot of attention...
Those who are socially engaged and well-connected can lower their risk of dementia. Researchers from Australia understand the general concept of social engagement as a health-promoting activity „that should be encouraged in our society.“ For many years, researchers focused on developing new drugs and therapies that would slow the progression...
The new Alzheimer's drug Lecanemab is raising great hopes for people with dementia and their caregivers. But which patient groups and how many affected individuals in Germany meet the criteria for treatment with Lecanemab? This essential question is a significant reason for us to dedicate another issue of our special newsletter to...
In recent weeks, we have informed you in several parts of our special newsletter SCHLAGLICHT – Medications for Dementia about new dementia drugs and challenges in everyday care. You can reread all published issues at any time in our digiDEM Bavaria newsletter archive: https://digidem-bayern.de/newsletter-archiv/. In the seventh and final issue of our special newsletter SCHLAGLICHT – Medications for Dementia, Michael...
